Clinical Trial Update: A Study Assessing the Efficacy and Safety of Deferasirox in Patients With Transfusion-dependent Iron Overload [Phase 3]

View source ↗

Summary

Phase 3 trial updating efficacy and safety of Deferasirox in patients with transfusion-dependent iron overload (completed).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Transfusion-dependent Iron Overload

Drugs mentioned

• Deferasirox (Deferasirox)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Transfusion-dependent Iron Overload | Phase 3 | Status: COMPLETED